| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
42,410,000 |
| Market
Cap: |
170.06(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.38 - $5.17 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Elevation Oncology is a precision oncology company focused on the development of targeted therapeutics for the treatment of cancer in genomically defined patient populations. Co.'s primary drug development candidate, seribantumab, is an Anti-HER3 monoclonal antibody and potential targeted therapy for solid tumors driven by neuregulin-1, a type of genomic alteration and oncogenic driver, and other receptor tyrosine-protein kinase erbB- (HER3), genomically defined cancers. Co. is also evaluating opportunities for pipeline expansion including prioritizing additional targeted therapy approaches in tumor types defined by genomic driver alterations.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
702,737 |
| Total Sell Value |
$0 |
$0 |
$0 |
$2,897,806 |
| Total People Sold |
0 |
0 |
0 |
1 |
| Total Sell Transactions |
0 |
0 |
0 |
1 |
| End Date |
2024-01-18 |
2023-10-17 |
2023-04-18 |
2022-04-18 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Cormorant Private Healthcare Fund Iii Lp |
10% Owner |
– – • |
2021-06-29 |
4 |
B |
$16.00 |
$4,000,000 |
I/I |
250,000 |
2,233,168 |
1.5 |
-32% |
|
| Cormorant Private Healthcare Fund Iii Lp |
10% Owner |
– – • |
2021-06-29 |
4 |
A |
$0.00 |
$0 |
I/I |
1,983,168 |
1,983,168 |
|
- |
|
| Royston Aaron |
10% Owner |
– – • |
2021-06-29 |
4 |
B |
$16.00 |
$10,000,000 |
D/D |
625,000 |
2,608,167 |
2.45 |
-32% |
|
| Royston Aaron |
10% Owner |
– – • |
2021-06-29 |
4 |
A |
$0.00 |
$0 |
D/D |
1,983,167 |
1,983,167 |
|
- |
|
| Schiff Dr Drew |
Managing Member |
– – – |
2021-06-29 |
4 |
B |
$16.00 |
$3,000,000 |
D/D |
187,500 |
2,834,910 |
2.44 |
-32% |
|
| Schiff Dr Drew |
Managing Member |
– – – |
2021-06-29 |
4 |
A |
$0.00 |
$0 |
D/D |
2,351,592 |
2,647,410 |
|
- |
|
| Qiming U.s. Healthcare Gp Ii, Llc |
10% Owner |
– – • |
2021-06-29 |
4 |
B |
$16.00 |
$5,000,000 |
D/D |
312,500 |
2,370,142 |
2.45 |
-32% |
|
| Qiming U.s. Healthcare Gp Ii, Llc |
10% Owner |
– – • |
2021-06-29 |
4 |
A |
$0.00 |
$0 |
D/D |
2,057,642 |
2,057,642 |
|
- |
|
| Vertex Global Hc Fund Ii Pte. Ltd. |
10% Owner |
– – • |
2021-06-29 |
4 |
B |
$16.00 |
$4,000,000 |
D/D |
250,000 |
2,307,642 |
2.45 |
-32% |
|
| Vertex Global Hc Fund Ii Pte. Ltd. |
10% Owner |
– – • |
2021-06-29 |
4 |
A |
$0.00 |
$0 |
D/D |
2,057,642 |
2,057,642 |
|
- |
|
| Leland Shawn |
President, CEOOfficer |
• • – |
2021-06-24 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
493,029 |
|
- |
|
| Schiff Dr Drew |
|
– – – |
2021-06-24 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
295,818 |
|
- |
|
12 Records found
|
1
|
Page 1 of 1 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
0.38 (8.66%) 
